Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Related Searches

Incidence of primary brain tumors

INTRODUCTION

Primary brain tumors are a diverse group of neoplasms arising from different cells of the central nervous system (CNS). Although uncommon, there is evidence that the incidence of these tumors has been rising for as much as fifty years. (See "Classification of gliomas", section on 'Histopathologic and molecular classification'.)

The incidence of primary malignant and benign brain tumors will be reviewed here. Risk factors for the development of brain tumors as well as the incidence of brain metastases are discussed separately. (See "Risk factors for brain tumors" and "Overview of the clinical manifestations, diagnosis, and management of patients with brain metastases".)

SOURCES OF DATA

The Central Brain Tumor Registry of the United States (CBTRUS) includes both benign and malignant lesions in its data collection. The CBTRUS was established in 1992 and compiles information from twelve state cancer registries [1]. Earlier data from the SEER program and other US cancer registries were limited to malignant brain tumors; however, as of 2004, data on nonmalignant brain tumors have been systematically collected by US cancer registries after the passage of Public Law 107-260, the Benign Brain Tumor Cancer Registries Amendment Act [2].

Inclusion of benign lesions is important to properly evaluate differences in etiology and to assess the potential impact of intervention studies. Benign lesions often produce the same neurologic symptoms as malignant tumors and distinguishing between benign and malignant based upon clinical grounds can be difficult. In addition, both benign and malignant lesions are frequently treated similarly with either surgical intervention or radiation therapy, and many malignant brain tumors probably originate from benign precursors. (See "Classification of gliomas", section on 'Histopathologic and molecular classification'.)

INCIDENCE AND MORTALITY

The US incidence rate for primary brain and nervous system tumors in adults (aged 20 years or older) is estimated to be 27.4 per 100,000 persons (data from 50 cancer registries, 2006 to 2010) [3]. Approximately one-third of tumors are malignant and the remainder are benign or borderline malignant [2,3].

          

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Nov 25, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. http://www.cbtrus.org/reports/reports.html (Accessed on October 12, 2010).
  2. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011; 103:714.
  3. Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 2013; 15 Suppl 2:ii1.
  4. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Fay MP, Feuer EJ, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2001, National Cancer Institute. Bethesda, MD seer.cancer.gov/csr/1975_2001 (Accessed on April 06, 2011).
  5. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002; 4:278.
  6. Davis FG, Freels S, Grutsch J, et al. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998; 88:1.
  7. Wen PY, Fine HA, Black PM, et al. High-grade astrocytomas. Neurol Clin 1995; 13:875.
  8. Preston-Martin S, Mack WJ. Neoplasms of the nervous system. In: Cancer Epidemiology and Prevention, 2nd, Shottenfeld D, Fraumeni JF (Eds), Oxford University Press, New York 1996.
  9. Chakrabarti I, Cockburn M, Cozen W, et al. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. Cancer 2005; 104:2798.
  10. Radhakrishnan K, Mokri B, Parisi JE, et al. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 1995; 37:67.
  11. Giordana MT, Schiffer P, Lanotte M, et al. Epidemiology of adult medulloblastoma. Int J Cancer 1999; 80:689.
  12. Davis DL, Ahlbom A, Hoel D, Percy C. Is brain cancer mortality increasing in industrial countries? Am J Ind Med 1991; 19:421.
  13. Modan B, Wagener DK, Feldman JJ, et al. Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol 1992; 135:1349.
  14. Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol 2006; 8:27.
  15. KURLAND LT. The frequency of intracranial and intraspinal neoplasms in the resident population of Rochester, Minnesota. J Neurosurg 1958; 15:627.
  16. Polednak AP. Interpretation of secular increases in incidence rates for primary brain cancer in Connecticut adults, 1965-1988. Neuroepidemiology 1996; 15:51.